Market Tracker

07/29 12:49pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

54.99
Real-Time Quote
 +1.68 / +3.15%
Today’s Change
44.50
Today|||52-Week Range
112.57
-14.48%
Year-to-Date

Today’s Trading

Previous close53.31
Today’s open53.04
Day’s range53.04 - 55.52
Volume203,488
Average volume (3 months)873,281
Market cap$4.0B
Dividend yield--
Data as of 12:34pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)+31.28%
Earnings growth (this year)-263.45%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-29.31%
P/E ratioNM
Price/Sales83.91
Price/Book12.57

Competitors

 Today’s
change
Today’s
% change
IDIXIdenix Pharmaceutica...+0.06+0.25%
ISISIsis Pharmaceuticals...+1.62+5.37%
CBSTCubist Pharmaceutica...+0.10+0.16%
PRXLPAREXEL Internationa...+0.76+1.41%
Data as of 12:47pm ET, 07/29/2014

Financials

Next reporting dateAugust 4, 2014
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$47.2M
Annual profit (last year)-$89.2M
Net profit margin-189.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts